Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-22-018271

President and CEO gave up 5,343 shares (to pay taxes)

  • President and CEO acquired 15,450 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Culley Brian M President and CEO 2022-06-30 Option exercise +15,450 113,237 D
Culley Brian M President and CEO 2022-06-30 Shares withheld for taxes −5,343 $1.58 $8,442 107,894 D
Derivatives
Culley Brian M President and CEO 2022-06-30 Option exercise · Restricted Stock Units −15,450 0 D
Loading xslF345X03/ownership.xml…